Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 28 7 2019
medline: 12 1 2021
entrez: 28 7 2019
Statut: ppublish

Résumé

The purpose of this study was the diagnostic evaluation of the hospital anxiety and depression scale total score, its depression subscale and the Beck depression inventory II in adults with congenital heart disease. This cross-sectional study evaluated 206 patients with congenital heart disease (mean age 35.3 ± 11.7 years; 58.3% men). Major depressive disorder was diagnosed by a structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders IV and disease severity with the Montgomery-Åsberg depression rating scale. Receiver operating characteristics provided assessment of diagnostic accuracy. Youden's J statistic identified optimal cut-off points. Fifty-three participants (25.7%) presented with major depressive disorder. Of these, 28 (52.8%) had mild and 25 (47.2%) had moderate to severe symptoms. In the total cohort, the optimal cut-off of values was >11 in the Beck depression inventory II, >11 in the hospital anxiety and depression scale and >5 in the depression subscale. Optimal cut-off points for moderate to severe major depressive disorder were similar. The cut-offs for mild major depressive disorder were lower (Beck depression inventory II >4; hospital anxiety and depression scale >8; >2 in its depression subscale). In the total cohort the calculated area under the curve varied between 0.906 (hospital anxiety and depression scale) and 0.93 (Beck depression inventory II). Detection of moderate to severe major depressive disorder (area under the curve 0.965-0.98) was excellent; detection of mild major depressive disorder (area under the curve 0.851-0.885) was limited. Patients with major depressive disorder had a significantly lower quality of life, even when they had mild symptoms. All scales were excellent for detecting moderate to severe major depressive disorder. Classification of mild major depressive disorder, representing 50% of cases, was limited. Therapy necessitating loss of quality of life is already present in major depressive disorder with mild symptoms. Established cut-off points may still be too high to identify patients with major depressive disorder requiring therapy. External validation is needed to confirm our data.

Identifiants

pubmed: 31349778
doi: 10.1177/2047487319865055
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-390

Commentaires et corrections

Type : CommentIn

Auteurs

Mechthild Westhoff-Bleck (M)

Department of Cardiology and Angiology, Hannover, Medical School, Germany.

Lotta Winter (L)

Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Germany.

Lukas Aguirre Davila (L)

Department of Biometrics, Hannover Medical School, Germany.

Christoph Herrmann-Lingen (C)

Department of Psychosomatic Medicine and Psychotherapy, University of Goettingen Medical Centre and German Centre for Cardiovascular Research, Germany.

Jens Treptau (J)

Department of Cardiology and Angiology, Hannover, Medical School, Germany.

Johann Bauersachs (J)

Department of Cardiology and Angiology, Hannover, Medical School, Germany.

Stefan Bleich (S)

Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Germany.

Kai G Kahl (KG)

Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH